Alnylam Pharmaceuticals, Inc. (ALNY)

399.49 +0.79 (+0.20%) USD  |  NASDAQ  |  Dec 24, 10:06
More

Alnylam Pharmaceuticals Return on Invested Capital (3y Median)

Return on Invested Capital (3y Median) Chart

View Return on Invested Capital (3y Median) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (3y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (3y Median) Range, Past 5 Years

View Return on Invested Capital (3y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (3y Median) Benchmarks

View Return on Invested Capital (3y Median) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Glaukos Corp. Upgrade
BridgeBio Pharma, Inc. Upgrade